Management of Constipation with Milk of Magnesia

Clinical Considerations

• Milk of magnesia is an osmotic laxative that works by drawing water into the intestines, making stool softer and easier to pass, and can be used as an inexpensive osmotic agent for constipation management, with an approximate daily cost of $1 or less 1
• The American Gastroenterological Association suggests milk of magnesia as part of a gradual approach to treating constipation, often after increasing fiber intake 1
• Typical dosing is approximately 1 oz (30 mL) twice daily, though once-daily dosing at bedtime is common and often sufficient 1

Efficacy and Comparative Effectiveness

• Magnesium-based laxatives are conditionally recommended for chronic idiopathic constipation based on very low-quality evidence 2, 3

Safety Considerations and Precautions

• Avoid use in patients with significant renal impairment (creatinine clearance <20 mL/min) due to risk of hypermagnesemia 2, 3

Algorithm for Use in Constipation Management

• Start with dietary modifications and increased fiber intake, then add milk of magnesia at 30 mL (2,400 mg) at bedtime if insufficient response, and consider adding a stimulant laxative or switching to PEG or other agents if constipation remains unresolved 1, 2, 3

Special Populations

• Elderly patients should use milk of magnesia with caution due to increased risk of electrolyte disturbances, and pregnant women should use it under medical supervision 4

Constipation Treatment with Magnesium Hydroxide

Mechanism of Action and Therapeutic Positioning

• The European Society for Medical Oncology (ESMO) and other guidelines strongly endorse osmotic laxatives, including magnesium salts and sulfate, for chronic constipation, considering them preferred laxatives in advanced diseases 5, 6, 7

Precautions and Contraindications

• The ESMO guidelines warn that excessive doses of oral magnesium salts can lead to hypermagnesemia, and should be used with caution in renal insufficiency, particularly in patients with significant renal impairment (creatinine clearance <20 mL/min) 5, 6, 7

Diagnostic Considerations

• The National Comprehensive Cancer Network (NCCN) suggests considering alternative approaches when constipation presents with diarrhea, as it may indicate fecal impaction with overflow, requiring a different management strategy 8

Contraindications and Precautions for Milk of Magnesia in Renal Insufficiency

Primary Contraindication: Renal Dysfunction

• The American Gastroenterological Association recommends avoiding milk of magnesia entirely when creatinine clearance is <20 mL/min due to the high risk of life-threatening hypermagnesemia 9
• The American Gastroenterological Association suggests using polyethylene glycol (PEG) 17g daily as a preferred osmotic laxative with durable 6-month response and no systemic absorption concerns in patients with chronic kidney disease 9
• The American Gastroenterological Association recommends using stimulant laxatives (bisacodyl, senna) as an alternative to magnesium-containing laxatives in patients with renal impairment, as they can be used short-term or as rescue therapy without renal concerns 9

Safer Alternative Laxatives for High-Risk Patients

• The American Gastroenterological Association recommends checking creatinine clearance before prescribing any magnesium-containing laxative, and using alternative laxatives such as PEG, lactulose, or stimulant laxatives in patients with creatinine clearance <20 mL/min 9
• The American Gastroenterological Association suggests that if creatinine clearance is >60 mL/min, magnesium-containing laxatives may be used with standard precautions, but monitoring for declining renal function is necessary 9

Contraindications and Precautions for Milk of Magnesia

Patient Populations Where Milk of Magnesia Should Be Avoided

• The European Society for Medical Oncology (ESMO) recommends against the use of saline laxatives, including magnesium hydroxide, in elderly cancer patients due to the risk of hypermagnesemia 10, 11
• Elderly patients should use magnesium hydroxide with extreme caution due to the risk of hypermagnesemia, and it has not been adequately studied in this population 10, 11
• Patients with cardiac or renal comorbidities should have laxatives individualized, particularly those on diuretics or cardiac glycosides, to avoid dehydration and electrolyte imbalances 10, 11
• Non-ambulatory patients with low fluid intake are at increased risk of complications when using magnesium hydroxide 10, 11

Contraindication of Magnesium‑Containing Laxatives and Antacids in Dialysis Patients

Contraindications

• Patients with end‑stage renal disease on chronic dialysis should avoid magnesium hydroxide (milk of magnesia) for constipation or acid reflux because it can cause life‑threatening hypermagnesemia. 12
• The American Gastroenterological Association recommends that magnesium oxide and all magnesium‑containing laxatives be avoided in individuals with renal insufficiency due to the risk of hypermagnesemia. 12

First‑Line Constipation Therapy

• Polyethylene glycol (PEG) 17 g daily is recommended as first‑line treatment for constipation in dialysis patients; this is a strong recommendation supported by moderate‑quality evidence, has no systemic absorption, demonstrates durable efficacy for at least six months, and its side‑effects are limited to mild gastrointestinal symptoms (abdominal distension, loose stool, flatulence, nausea). 12

Second‑Line Constipation Options

• Psyllium fiber may be used when dietary fiber intake is low and constipation is mild. 12
• Lactulose is an alternative for patients who fail or cannot tolerate PEG. 12
• Bisacodyl or sodium picosulfate can be employed as short‑term or rescue therapy. 12

Acid‑Reflux Management

• For acid reflux in dialysis patients, safe alternatives include calcium carbonate, proton‑pump inhibitors, and H₂‑receptor antagonists; H₂‑receptor antagonists are specifically endorsed. 12